Connection

Michael Gold to Hypoglycemic Agents

Back to Details
This is a "connection" page, showing publications Michael Gold has written about Hypoglycemic Agents.
Michael Gold
Connection Strength
0.070
Hypoglycemic Agents
  1. Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study. Dement Geriatr Cogn Disord. 2010; 30(2):131-46.
    View in: PubMed
    Score: 0.070
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.